{"_id":"T2DPt2nULCBVyM0k6NLJdVBcooxQCivdnTkeOX0ajIaxHGtZO8oOt4","founded_year":null,"lastupdate":"2024-09-16T00:00:00.000Z","update_date":"2024-09-16T00:00:00.000Z","lastModified":"Sep 16, 2024","confidence_score":12,"active":1,"confidence_score_reason":"funding stage, product stage, sector, founding year, founding month, number of employees, tags, invite member, business model, address, description, video or image, funding rounds, news, markets, external profiles, not claimed","urlname":"crispr-therapeutics","minimal_profile":1,"status":"","fullstatus":null,"acquired":null,"description_edited":null,"tag_line_edited":null,"phone":null,"registrar":null,"biverification":null,"recentupdates":[{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-09-16 15:09:11.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Automatic","datetime":"2024-09-16 15:09:11.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Automatic","datetime":"2024-09-16 15:09:11.000000","last_name":"Wein","first_name":"Ortal"}],"sectorverify":null,"biverify":null,"biverifydate":null,"crunchbaseid":null,"lastupdator":null,"lastupdator_email":null,"creator":"Ortal Wein","creator_email":"ortalw@sncentral.org","createdate":"2024-09-16T00:00:00.000Z","lastupdatedate":"2024-09-16","hide_reason":"TC54H7CXyKO8GmPECkbyKJf8n34r70JlfJTJHfo85exRpLaKI1Efs9","hide_reason_data":{"reason":"Pending approval - External entity","visible":0},"logokey":"$XutDeystsA4L0BEf2T6u48FDh4wLKescUNvVpTCPaYSENRmdqaEIPj.png","name":"CRISPR Therapeutics","israeliacquisitions":0,"forbesranking":null,"investmentarm":null,"investmentarmname":null,"hubname":null,"acquired_amount":null,"acquired_by":null,"acquired_country":null,"acquired_month":null,"acquired_year":null,"type":"Multinational","formernames":[],"alternativenames":null,"country":"United States","inisraelsince":"","inisraelsincemonth":"","isisraeli":0,"marketcapital":null,"marketcapitaldate":null,"oneliner":"Gene editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform.","website":"https://crisprtx.com/who-we-are","employees":null,"employees_exact":null,"employees_overall":null,"employees_overall_exact":null,"sociallinks":{"twitter":"","youtube":"","facebook":"","linkedin":"","instagram":""},"social":[],"flattenedsociallinks":null,"apps":{"appstore":"","googleplay":""},"investmentstage":[],"about":"Gene editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform.","founded":"","team":[],"portfolio":[{"name":"Averna Therapeutics","hidden":false,"raised":"$82M","founded":"2022","fullurl":"/company_page/averna-therapeutics","logokey":"$7acWD1R0tEO7bZlGuNhDvprDs38SR5zo7nSZjsqx83cGMkbyLu0hyr","urlname":"averna-therapeutics","employees":"51-200","company_id":"XLiMrj2b5u3GjfVI3DOVA5yhG0c9CObZfiNWwRagIvSnMZMZg1q383","description":"Genomic Medicines that Insert Therapeutic Genes into Safe Harbors Within the DNA","fundingstage":"A","businessmodel":"B2B, B2C","raisedNumber":82000000,"logourl":"https://storage.googleapis.com/clean-finder-353810/$7acWD1R0tEO7bZlGuNhDvprDs38SR5zo7nSZjsqx83cGMkbyLu0hyr","style":"","hiddenCompanyTooltip":""}],"exits":[],"mediagallery":[],"affiliatedOrganizations":null,"address":{"israeli":null,"officesabroad":null},"headquarter_address":null,"news":[],"extensions":null,"events":null,"hide_reasons":[{"id":"75T5aG1f0dpqYFonup40lXNjO046zUH82TaHW1TAiIMf9aYAsSOl0d","reason":"No relevant activity"},{"id":"7KVi9S7qqUtO0WCsFclwqBEZluejfNYqWC1Uhx0tPHtDxtvxPPaCPH","reason":"No longer active"},{"id":"hoyKAmu4YJEHmhtLwCdeFldSnDwaVbPXOnH0RA9hKHCzAcHO6OOrXd","reason":"Pending approval"},{"id":"TC54H7CXyKO8GmPECkbyKJf8n34r70JlfJTJHfo85exRpLaKI1Efs9","reason":"Pending approval - External entity"}],"timeline":[],"techcommunityinvolvement":null,"tags":[],"investments":[],"funds":[],"databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Multinational","parsedName":"CRISPR Therapeutics","logourl":"https://storage.googleapis.com/clean-finder-353810/$XutDeystsA4L0BEf2T6u48FDh4wLKescUNvVpTCPaYSENRmdqaEIPj.png","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$XutDeystsA4L0BEf2T6u48FDh4wLKescUNvVpTCPaYSENRmdqaEIPj.png","teamMembersNumber":0,"nationality":"Foreign","communityinvolvement":[],"popup_claim_profile":"false","claimedBadge":"none","display":{"mainContact":"none"},"mainContact":{},"_eventview":{"publicoffering_exit":[],"privateequityfunding":[],"nonequityfunding":[],"merger_acquisitions":[],"others":[]}}